Finley E M, Ratz J L
Department of Dermatology, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA 70121, USA.
J Am Acad Dermatol. 1996 Mar;34(3):465-9. doi: 10.1016/s0190-9622(96)90441-7.
Hidradenitis suppurativa is a disabling disease. Although medical management can at times control the disease, the treatment of choice is surgical excision. Surgical defects have been managed by second-intention healing, simple surgical closure, or complex surgical repairs.
Our purpose was to determine the benefit of carbon dioxide laser excision with healing by second intention to treat lesions of hidradenitis suppurativa.
We treated seven patients who had axillary and inguinoperineal hidradenitis suppurativa with carbon dioxide laser excision followed by second-intention healing. A total of 12 procedures were performed (five bilateral and two unilateral). Follow-up periods were 10 to 27 months.
After a healing time of 4 to 8 weeks, scars were flat and linear. Only one recurrence of hidradenitis suppurativa has been observed; this occurred along the margin of the surgical scar in a previously treated area. Some patients, however, had continued disease activity in untreated areas. All subjects were satisfied with the results of the procedure, and complications were minimal.
Carbon dioxide laser excision with second-intention healing is safe and effective for hidradenitis suppurativa.
化脓性汗腺炎是一种致残性疾病。尽管药物治疗有时可以控制病情，但首选的治疗方法是手术切除。手术缺损的处理方式包括二期愈合、简单手术缝合或复杂手术修复。
我们的目的是确定二氧化碳激光切除并二期愈合治疗化脓性汗腺炎病变的益处。
我们对7例患有腋窝和腹股沟会阴化脓性汗腺炎的患者采用二氧化碳激光切除，随后二期愈合。共进行了12次手术（5次双侧和2次单侧）。随访时间为10至27个月。
经过4至8周的愈合时间后，瘢痕扁平且呈线性。仅观察到1例化脓性汗腺炎复发；这发生在先前治疗区域的手术瘢痕边缘。然而，一些患者在未治疗区域仍有疾病活动。所有受试者对手术结果满意，并发症极少。
二氧化碳激光切除并二期愈合治疗化脓性汗腺炎安全有效。
